Recurrent macrophage activation syndrome (MAS) is very rare. We present the case of an adolescent boy with human leukocyte antigen (HLA) B27-positive ankylosing spondylitis (AS), who experienced episodes of recurrent MAS since he was a toddler. A 16-year-old boy was admitted because of remittent fever with pancytopenia and splenomegaly after surgical intervention for an intractable perianal abscess. He had been diagnosed with hemophagocytic lymphohistiocytosis (HLH) 4 different times, which was well controlled with intravenous immunoglobulin and steroids since the age of 3. We were unable to identify the cause for the HLH. He remained symptom-free until the development of back pain and right ankle joint pain with swelling at 15 years of age. He was diagnosed with HLA B27-positive AS with bilateral active sacroiliitis. He showed symptom aggravation despite taking naproxen and methotrexate, and the symptoms improved with etanercept. On admission, his laboratory data showed leukopenia with high ferritin and triglyceride levels. Bone marrow biopsy examination showed histiocytic hyperplasia with hemophagocytosis. There was no evidence of infection. He received naproxen alone, and his symptoms and laboratory data improved without any other immunomodulatory medications. Genetic study revealed no primary HLH or inflammasome abnormalities. In this case, underlying autoimmune disease should have been considered as the cause of recurrent MAS in the young patient once primary HLH was excluded.
Introduction
Macrophage activation syndrome (MAS) is characterized by fever, hepatosplenomegaly, severe cytopenia, serious liver disease, and coagulopathy 1) . MAS is a severe, potentially fatal condition associated with excessive activation of immune cells, leading to hypercyto kinemia and overwhelming systemic inflammatory reactions with hemophagocytosis due to defective immune regulation 1, 2) . MAS is used to describe secondary hemophagocytic lymphohistiocytosis (HLH) associated with autoimmune disease. Primary HLH developed in genetic disorder, but secondary HLH is triggered by various etiologies including infection, medication, malignancies, and autoimmune diseases 13) . In autoimmune disease, hypercytokinemia in systemic inflammatory response may induce MAS. The annual incidence of HLH in children was reported as 1 in 800,000 4) . About 10% of secondary HLH, called as MAS, were associated with autoimmune disor ders 4) , and MAS occurred frequently in 10%-20% of systemic juvenile idiopathic arthritis 4, 5) . Recurrent MAS or HLH was de veloped in underlying genetic disorders, but is rare in secondary cause 2, 6) . MAS in ankylosing spondylitis (AS) was very rare in literature review 5, 7) . We reported a case of recurrent MAS in AS since toddler age, although we could not identify etiology of recurrent HLH until adolescent age.
Case report
A 16yearold boy was transferred from Department of Surgery due to remittent fever with pancytopenia and splenomegaly despite of improvement of septic shock without any organisms. He had received fistulectomy with colostomy due to intractable perianal abscess 2 months previously. He had been diagnosed with HLH according to HLH 1994 guideline at 3 years of age 8) , and had been treated with intravenous immunoglobulin (IVIG). HLH recurred 3 years later, and he was treated according to HLH 2004 protocol including dexamethasone, etoposide, and cyclo sproin A 9) , and remained symptoms free without maintenance therapy. He relapsed again at ages 7 and 8, but we were unable to identify any causes. He received maintenance prednisolone treatment for 2 years after 4th attack.
He was symptom free until 15 years of age. He complained back and both knee joints pain with right ankle swelling for 1 month at June, 2012. We performed ultrasonography for synovial fluid from joints. Sonographic findings showed profound amount of fluid collection on suprapatellar recess and synovial hyper trophy. We aspirated about 50 mL of synovial fluid with 10,000/ µL of white blood cell (WBC, 66% segmented neutrophil, 16% lymphocyte, 18% monocyte). Human leukocyte antigen (HLA) B27 was positive in genetic study of patient. Magnetic resonance imaging findings for sacroiliac joints (SI) showed both SI joint cartilage abnormalities with erosion of right SI and bone marrow edema. He was diagnosed with HLA B27 positive juvenile AS compatible with bilateral sacroiliitis (Fig. 1) . We began medica tion with naproxen and methotrexate, but showed symptom aggrava tion. His symptoms remained with 4.75 of Bath Ankylos ing Spondylitis Disease Activity Index (BASDAI) at 4 month later. He did not complaint pain after Eternacept treatment. His BASDAI was 1.6 before development of intractable perianal ab scess. He was admitted to department of surgery for surgical intervention with fistulectomy and colostomy. However, he developed fever and signs of septic shock, and was treated with antibiotics and IVIG.
On physical examination, he was febrile with splenomegaly. His wound was clean state without any inflammation finding. His laboratory data showed WBC count 1,240/µL, platelet 44,000/µL, ferritin 2,707 ng/mL, triglyceride 343 mg/dL, aspatate transa minase 238 IU/L, alanine transaminase 145 IU/L, and fibrinogen 96 mg/dL. We performed bone marrow aspiration and biopsy, which showed histiocytic hyperplasia with hemophagocytosis. There was no serologic evidence of any viral infections including EpsteinBarr (EB) virus. We diagnosed with MAS from HLA B27 positive AS. He received naproxen only, and improved without any other im munomodulatory medication. Fever was dropped after medica tion, and his symptoms were improved, even though persistent splenomegaly. Also, his laboratory data returned to near normal range within 4 weeks. We evaluated gene study for primary HLH and inflammasome, and got no any genetic abnormalities 2, 6) . We described his clinical course and treatments of MAS and JAS since 3 years old as Fig. 2 .
This study was approved by Institute of Review Board from Seoul St. Mary's Hospital, College of Medicine, The Catholic Uni versity of Korea (KC16ZISE0297). 
Discussion
The clinical criteria for HLH include many nonspecific findings that overlap with severe inflammatory conditions 1, 2) . Hemo phagocytosis is a pathologic finding that activated macro phages phagocyte blood cells due to inappropriate immune response 1, 2, 4) . The causes of HLH are due to genetic defects (pri mary) or various etiologies including infections or auto immune diseases (secon dary) 3, 8, 9) . MAS is called as acute systemic inflam mation from autoimmune disease or autoinflammatory condi tions including systemic juvenile idiopathic arthritis or systemic lupus erythema tosus 3, 5, 10) . MAS is rarely reported in AS 5, 7) . In our case, an adoles cent boy experienced recurrent HLH controlled by immunosup pressive agents since toddler age. He was diag nosed with JAS at 15 yearold.
The diagnostic criteria of HLH was based on HLH2004 diag nostic guideline, as follow as presence of a molecular diagnosis consistent with HLH including Munc gene or meeting 5 of 8 clinical and laboratory diagnostic criteria including fever, hepato splenomegaly, cytopenia, hypertriglyceridemia/hypofibrino genemia, hemophagocytosis, low or absent Natural Killer (NK) cell activity, ferritin over 500 ng/mL, and soluble CD25 over 2,400 9) . The pre liminary diagnostic guidelines of MAS in auto immune disease consisted of at least 2 laboratory criteria or the presence of at least one laboratory criterion including cytopenia, elevated levels of AST and lactic dehydrogenase, hypofibrinoge nemia, hyperferri tinemia, hypertriglyceridemia, and one clinical criterion including fever, hepatosplenomegaly, hemorrhagic manifestations, and central nervous system dysfunction 3) . He was diagnosed with MAS after JAS, compatible findings with fever, cytopenia, sple nomegaly, hyperferritinemia, hypertriglyceridemia, elevated with AST, and hypofibrinogenemia.
Juvenile ankylosing spondylitis (JAS) is included in the enthe sitis related arthritis, and diagnosed with over 6week symptoms and 8 years by International League of Association for Rheuma tology 11) . JAS is a strong genetic predisposition as the high fre quency of positive HLA B27. The prevalence of AS is around 0.2% in general population 12) , and symptoms developed only 10%-20% before age 16 11) . The pathogenesis of JAS was related with HLA B27, and autoreactive CD8 T cells recognized peptide presentation on HLA B27 heavy chain misfolding, and produced various cytokines including TNFα and IL1 13, 14) . These cytokines induced inflammation to joints and new bone formation 14) . He complained back and joint pain over 6 weeks at 15 years old, and was diagnosed with JAS according to sacroiliac inflammation and positive HLA B27. We did not evaluated HLA B27 until joint symptoms developed.
This patient experienced recurrent HLH since toddler age, but he was tolerable with low dose steroid after HLH94 or HLH 2004 treatment protocol 8, 9) . The result of negative perforin gene sug gested that his clinical course was fortunately not fatal. When he relapsed HLH, we evaluated etiology including viral infections, and did not identify. The patient with relapsed HLH received chemotherapy or hematopoietic stem cell transplantation accord ing to HLH treatment protocol 8, 9) . However, he was very tolerable in spite of low dose steroid. In diagnostic criteria of JAS, joint symptoms were developed since at least 8 years old 11) . He was diagnosed with JAS at 15 years old. In this patient, recurrent HLH might be related with underlying JAS pathogenesis. In our case, HLA B27 would be contributed to immune dysregulation for CD8 T cell activation 1315) . The autoreactive CD8 T cells might produce profound cytokines and induce clinical manifestations of HLH 1, 2, 5) . This immunologic background might be related with recurrent HLH since toddler age.
For identifying underlying genetic autoinflammatory disease, we evaluated genetic study for inflammasome because of recur rent MAS 6) . We did not find out any genetic abnormalities related with NLRC4. Therefore, immunologic aspect with recurrent MAS might be only associated with HLA B27 in this patient, respec tively.
We reported that an adolescent boy with JAS experienced re current MAS since toddler age. We suggest that underlying auto immune disease should be considered as the cause of recurrent MAS in a young patient after primary HLH has been excluded. 
